Combining ICI With SBRT or HypoFrx-RT for ES NSCLC

NCT05451173 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

83

Enrollment

OTHER

Sponsor class

Conditions

Non-small Cell Lung Cancer
Non-small Cell Carcinoma
Non-small Cell Lung Cancer Stage I
Non-small Cell Lung Cancer Stage II
Non-small Cell Lung Cancer Stage III

Interventions

RADIATION: Stereotactic body radiotherapy
RADIATION: Hypofractionated radiotherapy
DRUG: Durvalumab

Sponsor

Alexander Chi